Cytidine deaminase inhibitors for the treatment of pancreatic cancer
US-2019076464-A1 · Mar 14, 2019 · US
US12187757B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12187757-B2 |
| Application number | US-202017766074-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 7, 2020 |
| Priority date | Oct 8, 2019 |
| Publication date | Jan 7, 2025 |
| Grant date | Jan 7, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to methods of synthesizing 2′-deoxy-2′,2′-difluorotetrahydrouridine with increased purity and uniform particle size distribution. In particular, methods of the invention include crystallization and isolation procedures rendering synthetic reaction intermediates. The invention further includes compositions comprising the final compound in highly pure form, including lower number of impurities and lower levels of individual and total impurities.
Opening claim text (preview).
What is claimed is: 1. A method of producing compound 1: or a salt thereof; comprising the steps of: (a) hydrogenating a compound of Formula IV: wherein R is a hydroxyl protecting group, to produce a compound of Formula IIa: (b) reducing the compound of Formula IIa to produce a compound of Formula IIIa: (c) deprotecting the compound of Formula IIIa to produce compound 2: and (d) precipitating or crystallizing compound 2 in the presence of a catalyst to produce compound 1: or a salt thereof; wherein the method comprises the following steps: (i) wherein the hydrogenating step (a) is performed under hydrogen atmosphere with a palladium catalyst; (ii) wherein the reducing step (b) is performed at a temperature of about −12° C. to about −5° C.; (iii) wherein the deprotecting step (c) is performed in the presence of an organic base; and (iv) wherein the work-up of the deprotected compound from deprotecting step (c) is performed under non-aqueous conditions. 2. The method of claim 1 , wherein the catalyst is about 1 mol % to about 20 mol % 1,8-diazabicyclo(5.4.0)undec-7-ene (DBU). 3. The method of claim 2 , wherein the catalyst is about 5 mol % DBU. 4. The method of claim 1 , wherein the catalyst is acetic acid, trifluoroacetic acid, diisopropylethylamine, or ammonium hydroxide. 5. The method of claim 1 , wherein the deprotecting step (c) further comprises a step of trituration. 6. The method of claim 1 , further comprising recrystallizing or slurrying compound 1. 7. The method of claim 6 , wherein the recrystallizing is performed at a pH of about 6.0 to about 7.4 and carried out by dissolving compound 1 at a temperature of about 50° C. to about 55° C. to produce a solution and then cooling the solution to about 5° C. 8. The method of claim 1 , wherein step (d) is carried out in the presence of a solution comprising acetonitrile. 9. The method of claim 1 , wherein step (d) is carried out in the presence of a solution comprising acetone or tetrahydrofuran. 10. The method of claim 1 , wherein step (b) is carried out in the presence of CeCl 3 . 11. The method of claim 1 , wherein the R is a benzoyl group. 12. The method of claim 1 , wherein the palladium catalyst used in step (i) is palladium on charcoal (Pd/C). 13. The method of claim 12 , wherein the amount of the Pd/C used in step (i) is a catalytic amount of not more than 0.1 part by weight per one part by weight of the compound of Formula IV. 14. The method of claim 12 , wherein the amount of the Pd/C used in step (i) is 0.025 to 0.05 parts by weight per one part by weight of the compound of Formula IV. 15. The method of claim 1 , wherein step (i) is performed in a mixed solvent comprising ethyl acetate, acetic acid, and water. 16. The method of claim 1 , wherein step (i) is performed under ambient or increased pressure. 17. The method of claim 1 , wherein step (i) is performed under increased pressure of 0.1 to 0.5 MPa. 18. The method of claim 1 , wherein the organic base used in step (iii) is one or more bases selected from the group consisting of DBU, triethylamine, DMAP, and DABCO. 19. The method of claim 1 , wherein the amount of the organic base used in step (iii) is 0.01 to 2.2 moles per mole of the compound of Formula IIIa. 20. The method of claim 1 , wherein the organic base used in step (iii) is DBU.
Processes for the preparation of sugar derivatives · CPC title
Heterocyclic radicals containing only nitrogen atoms as ring hetero atom · CPC title
Imides, amides or imidates (R-C=NR(OR)) · CPC title
Palladium · CPC title
Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.